Axcan Pharma Inc. — Investor Relations & Filings
Filings indexed
198
across all filing types
Latest filing
2008-02-26
Regulatory Filings
Country
CA
Canada
Listing
TSX
AXCA
Axcan Pharma Inc. was a specialty pharmaceutical company focused on the development and commercialization of prescription products for diseases and disorders involving the digestive system. The company specialized in providing effective therapies for a range of gastrointestinal conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and cholestatic diseases. Axcan marketed a broad line of products, such as pancrelipase capsules, aimed at improving the quality of care for patients suffering from chronic GI ailments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2008-02-26 | English | |
| Other securityholders documents - English.PDF | 2008-01-14 | English | |
| Material change report - French.PDF | 2007-12-04 | English | |
| Other.pdf | 2007-10-10 | English | |
| Material change report - English.pdf | 2007-08-07 | English | |
| Other.pdf | 2007-07-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2008
2 filings
| |||||
| 47821459 | Material change report - English.pdf | 2008-02-26 | English | ||
| 47821461 | Other securityholders documents - English.PDF | 2008-01-14 | English | ||
|
2007
7 filings
| |||||
| 47821463 | Material change report - French.PDF | 2007-12-04 | English | ||
| 47821465 | Other.pdf | 2007-10-10 | English | ||
| 47821467 | Material change report - English.pdf | 2007-08-07 | English | ||
| 47821469 | Other.pdf | 2007-07-04 | English | ||
| 47821471 | Other.pdf | 2007-06-21 | English | ||
| 47821473 | Material change report - English.pdf | 2007-06-14 | English | ||
| 47821476 | Other.pdf | 2007-05-14 | English | ||
|
2006
6 filings
| |||||
| 47821480 | Material change report - English.pdf | 2006-12-19 | English | ||
| 47821482 | Material change report - English.pdf | 2006-12-11 | English | ||
| 47821484 | Material change report - English.pdf | 2006-09-25 | English | ||
| 47821486 | Material change report - English.pdf | 2006-05-11 | English | ||
| 47821651 | Material change report - English.pdf | 2006-05-08 | English | ||
| 47821653 | Material change report - English.pdf | 2006-02-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Changchun Bcht Biotechnology Co.
Biopharmaceutical firm focused on the R&D and production of…
|
688276 | CN | Manufacturing |
|
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.
A diversified group focused on biopharmaceuticals, vaccines…
|
000661 | CN | Manufacturing |
|
Changzhou Qianhong Bio-pharma Co.,Ltd
Develops and manufactures heparin and enzyme biochemical me…
|
002550 | CN | Manufacturing |
|
Charlotte's Web Holdings, Inc.
Pioneer and market leader in whole-plant hemp-derived CBD w…
|
CWEB | CA | Manufacturing |
|
CHA Vaccine Research Institute
Develops vaccines and immunotherapeutics using proprietary …
|
261780 | KR | Manufacturing |
|
CHEIL BIO CO., LTD.
Develops and manufactures veterinary medicines and function…
|
052670 | KR | Manufacturing |
|
CHEMCLIN DIAGNOSTICS CO., LTD.
Develops IVD systems and reagents using proprietary LiCA te…
|
688468 | CN | Manufacturing |
|
Chemical Works of Gedeon Richter Plc
Vertically integrated pharma company focused on women's hea…
|
RICHT | HU | Manufacturing |
|
Chemokine Therapeutics Corp.
Developed chemokine-based therapies (peptide drugs) for can…
|
CHKT | CA | Manufacturing |
|
Chemomab Therapeutics Ltd.
Clinical-stage biotech developing therapeutics for fibro-in…
|
CMMB | US | Manufacturing |
Axcan Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/43169/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=43169 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=43169 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=43169 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 43169}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Axcan Pharma Inc. (id: 43169)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.